The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
Brief Report
PreviousPrevious
Volume 358:811-817 February 21, 2008 Number 8
NextNext

Hepatitis E Virus and Chronic Hepatitis in Organ-Transplant Recipients
Nassim Kamar, M.D., Ph.D., Janick Selves, M.D., Jean-Michel Mansuy, M.D., Leila Ouezzani, M.D., Jean-Marie Péron, M.D., Ph.D., Joëlle Guitard, M.D., Olivier Cointault, M.D., Laure Esposito, M.D., Florence Abravanel, Pharm.D., Marie Danjoux, M.D., Dominique Durand, M.D., Jean-Pierre Vinel, M.D., Jacques Izopet, Pharm.D., Ph.D., and Lionel Rostaing, M.D., Ph.D.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-PowerPoint Slide Set
-Supplementary Material
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
SUMMARY

Hepatitis E virus (HEV) is considered an agent responsible for acute hepatitis that does not progress to chronic hepatitis. We identified 14 cases of acute HEV infection in three patients receiving liver transplants, nine receiving kidney transplants, and two receiving kidney and pancreas transplants. All patients were positive for serum HEV RNA. Chronic hepatitis developed in eight patients, as confirmed by persistently elevated aminotransferase levels, serum HEV RNA, and histologic features of chronic hepatitis. The time from transplantation to diagnosis was significantly shorter and the total counts of lymphocytes and of CD2, CD3, and CD4 T cells were significantly lower in patients in whom chronic disease developed.


Source Information

From the Department of Nephrology, Dialysis, and Multiorgan Transplantation (N.K., L.O., J.G., O.C., L.E., D.D., L.R.) and INSERM Unité 858, IFR 31 (N.K., J.-M.P.), Centre Hospitalier Universitaire, Rangueil, France; and the Departments of Histopathology (J.S., M.D.), Virology (J.-M.M., F.A., J.I.), and Hepatology (J.-M.P., J.-P.V.), and INSERM Unité 563, IFR 30 (F.A., J.I., L.R.), Centre Hospitalier Universitaire, Purpan — all in Toulouse, France.

Address reprint requests to Dr. Kamar at the Department of Nephrology, Dialysis, and Multiorgan Transplantation, CHU Rangueil, TSA 50032, 31059 Toulouse CEDEX 9, France, or at kamar.n{at}chu-toulouse.fr.

Full Text of this Article


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.